Autopsy report · NCT06052345

Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle Outcomes

“No accrual”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Theodoros Foukakis

Sponsor type

University, hospital or other

Conditions

Breast Neoplasms; Breast Cancer; Early-stage Breast Cancer; Non-Metastatic Breast Carcinoma; Polyneuropathy Due to Drugs; Polyneuropathy; Drug

Interventions

Garmin smartwatch; REBECCA Mobile application; REBECCA PC plug-in

Participants

0

Sites

1

Countries

Sweden

Trials that died the same way

• A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer
  “No accruals” (96% match in meaning)
• Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic Disorders
  “0 accrual” (83% match in meaning)
• Dose Escalated Proton Beam Therapy or Photon Therapy for Esophageal Cancer
  “non-accrual” (82% match in meaning)
• INTERVAL: Ipilimumab and Nivolumab Combination Therapy: A Study of a Supervised or Semi-Supervised Exercise InteRVention or Usual Care With Functional Capacity and Quality of Life Evaluations in Subjects With Advanced or Metastatic RenAL Cell Carcinoma
  “Poor accrual” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.